Cortia depressa
Cortia depressa · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cortia depressa is a unique botanical species that has garnered significant interest within the field of phytotherapy. Researchers are increasingly focusing on the development of various plant extracts derived from its specialized tissues. These preparations are being studied for their potential bioactive compounds and therapeutic properties. By isolating specific chemical constituents, scientists aim to harness the plant's natural efficacy for medicinal use. Understanding the chemical profile of these extracts remains essential for advancing modern pharmacological applications.
- Synonyms
- Schulzia Lindleyi · Schulzia Nepalensis · 4 more
- Common names
- Not available
- Family
- Apiaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Synonyms
Cortia depressa is a botanical species characterized by a complex history of taxonomic classifications. Throughout various scientific studies, it has been identified by several different synonyms, including Athamanta depressa and Cortia lindleyi. Researchers have also documented its existence under the names Cortia nepalensis and Daucus depressus. Furthermore, the plant has been referred to in historical literature as Schulzia lindleyi. Understanding these diverse nomenclature relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cortia depressa is a unique botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, it is specifically classified under the class Equisetopsida. The plant is a member of the order Apiales, which helps define its evolutionary lineage. Further narrowing its identity, it falls under the family Apiaceae. Finally, it is distinguished by its unique placement within the genus Cortia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Apiales |
| Family | Apiaceae |
| Genus | Cortia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cortia depressa exhibits a diverse geographical range that spans across several distinct regions of Asia. In temperate climates, this species is found within China and Tibet. Its presence extends significantly into tropical zones, particularly throughout the Indian Subcontinent. Within this area, it inhabits specific locales such as Nepal, Pakistan, and the West Himalaya. Additionally, the plant is documented across the East Himalaya, illustrating its broad ecological adaptability.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cortia depressa is a delicate herb that maintains a self-supporting growth form. This small plant is characterized by its diminutive stature, typically reaching a maximum height of only 0.1 m. Depending on its environment, its height generally fluctuates between a minimum of 0.05 m and 0.075 m. These specific measurements define its compact presence within its natural habitat. Such modest dimensions allow it to thrive effectively in its specialized ecological niche.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Cortia depressa serves as a significant medicinal plant extract that can be used to treat triple-negative breast cancer (TNBC). While this plant does not cause apparent cytotoxicity when administered as a single regimen, it demonstrates powerful therapeutic potential through combination therapy. Specifically, it shows significant synergistic effects when used in conjunction with the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). This synergy works against both the MDA-MB-231 and MDA-MB-468 TNBC cell lines to enhance cell death. Consequently, Cortia depressa represents a promising candidate for overcoming resistance mechanisms in aggressive breast cancer treatments.
Preparations
Cortia depressa is prepared as plant extracts to investigate its potential therapeutic applications in cancer treatment. In this specific study, these extracts were screened for their ability to sensitize triple-negative breast cancer cells to TRAIL. While the plant extract did not cause significant cytotoxicity when used as a single regimen, it demonstrated a powerful synergistic effect when combined with TRAIL. This interaction helps overcome resistance mechanisms in aggressive cancer cell lines like MDA-MB-231 and MDA-MB-468. Consequently, the preparation of Cortia depressa into medicinal extracts offers a promising pathway for developing new combination therapies.